Cite Filings / EDSA / 0001104659-26-122821
Feed Companies Filings Check
Sign in
SCHEDULE 13G/A

Statement of Beneficial Ownership

Edesa Biotech, Inc. · Filed 2026-11-04 · Acc 0001104659-26-122821

Documents 1

  • SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

  • 2026-11-16 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-11-09 8-K Material agreement · Agreement ended · Regulation FD disclosure
  • 2026-11-05 4 Chief Executive Officer acquired 18,677 shares (grant or award)
  • 2026-11-04 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-10-29 4 Chief Executive Officer acquired 27,602 shares (grant or award)
  • 2026-05-15 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G · Boxer Capital Management, LLC 6.9%
  2. 2026-11-16 SCHEDULE 13G/A · Perceptive Advisors LLC 4.2%
  3. 2026-11-16 SCHEDULE 13G/A · Rubric Capital Management LP 4.61%
  4. 2026-11-16 SCHEDULE 13G · StemPoint Capital LP 9.9%
  5. 2026-11-16 SCHEDULE 13G/A · Sirenia Capital Management LP 9.9%
Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…